[ibd-display-video id=2385970 width=50 float=left autostart=true] IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
History reveals that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves. See if Marsh & Mclennan can continue to rebound and hit that benchmark.
While Marsh & Mclennan is not near a proper buy point right now, see if it manages to form and break out from a proper chart pattern .
The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 10% to 14%. Revenue rose from 4% to 7%.
The company holds the No. 3 rank among its peers in the Insurance-Brokers industry group. Fanhua ( FANH ) is the top-ranked stock within the group.